Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T CellsAaron P. Rapoport, Carl H. June, Nicole A. Aqui et al.|Clinical Cancer Research|2014Cited by 123
Associations of TP53 mutations, codon 72 polymorphism and human papillomavirus in head and neck squamous cell carcinoma patientsQi Shi, Xiao‐Ping Dong, Kang Xiao et al.|Oncology Reports|2013Cited by 10
Identification and Analysis of Novel Biomarkers Involved in Chromophobe Renal Cell Carcinoma by Integrated Bioinformatics AnalysesWei Zhang, Jun Wu, Yin Xu et al.|BioMed Research International|2020Cited by 10
Supplementary Figure 1 from Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T CellsAaron P. Rapoport, Carl H. June, Nicole A. Aqui et al.|Unknown|2023Cited by 0
Supplementary Figure 2 from Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T CellsAaron P. Rapoport, Carl H. June, Nicole A. Aqui et al.|Unknown|2023Cited by 0